Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'mda dopamine' OR with Authors including 'mda dopamine' OR with Abstract including 'mda dopamine' OR with Keywords including 'mda dopamine'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Lopatka JE, Brewerton CN,... The protective effects of methysergide, 6-hydroxydopamine and other ag... Res Commun Chem Path... 1976
Marquardt GM, DiStefano V... Pharmacological and Toxicological Effects of B-3,4-Methylenedioxyamphe... Toxicol.Appl.Pharmac... 1978
Johnson MP, Hoffman AJ, N... Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... Eur J Pharmacol 1986
Lyon RA, Glennon RA, Tite... 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions... Psychopharmacology (... 1986
Stone DM, Stahl DC, Hanso... The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... Eur J Pharmacol 1986
Glennon RA, Yousif M, Nai... Methcathinone: a new and potent amphetamine-like agent Pharmacol Biochem Be... 1987
Battaglia G, Yeh SY, O'He... 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... J Pharmacol Exp Ther 1987
Gibb JW, Stone DM, Stahl ... The effects of amphetamine-like designer drugs on monoaminergic system... NIDA Res Monogr 1987
Steele TD, Nichols DE, Yi... Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and... Biochem Pharmacol 1987
Gold LH, Koob GF Methysergide potentiates the hyperactivity produced by MDMA in rats Pharmacol Biochem Be... 1988
Johnson M, Letter AA, Mer... Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... J Pharmacol Exp Ther 1988
Mansbach RS, Braff DL, Ge... Prepulse inhibition of the acoustic startle response is disrupted by N... Eur J Pharmacol 1989
Nichols DE, Oberlender R,... Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA... Pharmacol Biochem Be... 1989
Cho AK, Hiramatsu M, Dist... Stereochemical differences in the metabolism of 3,4-methylenedioxymeth... Drug Metab Dispos 1990
Finnegan KT, Skratt JJ, I... The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... Neurosci Lett 1990
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
Glennon RA Phenylalkylamine stimulants, hallucinogens, and designer drugs NIDA Res Monogr 1991
Hiramatsu M, DiStefano E,... A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effect... Eur J Pharmacol 1991
Johnson M, Bush LG, Gibb ... Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... Eur J Pharmacol 1991
Johnson MP, Huang XM, Nic... Serotonin neurotoxicity in rats after combined treatment with a dopami... Pharmacol Biochem Be... 1991
McCann UD, Ricaurte GA Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not m... Brain Res 1991
Yeh SY, Hsu FL The neurochemical and stimulatory effects of putative metabolites of 3... Pharmacol Biochem Be... 1991
Farfel GM, Vosmer GL, Sei... The N-methyl-D-aspartate antagonist MK-801 protects against serotonin ... Brain Res 1992
Paulus MP, Geyer MA The effects of MDMA and other methylenedioxy-substituted phenylalkylam... Neuropsychopharmacol... 1992
Monte AP, Marona-Lewicka ... Synthesis and pharmacological examination of benzofuran, indan, and te... J Med Chem 1993
Miller DB, O'Callaghan JP Environment-, drug- and stress-induced alterations in body temperature... J Pharmacol Exp Ther 1994
O'Callaghan JP, Miller DB Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... J Pharmacol Exp Ther 1994
Hegadoren KM, Martin-Iver... Comparative behavioural and neurochemical studies with a psychomotor s... Psychopharmacology (... 1995
Sprague JE, Nichols DE The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-meth... J Pharmacol Exp Ther 1995
Miller RT, Serrine SL, Mo... Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracere... Chem Res Toxicol 1995
Miller RT, Lau SS, Monks ... Effects of intracerebroventricular administration of 5-(glutathion-S-y... Chem Res Toxicol 1996
Finnegan KT, Taraska T Effects of glutamate antagonists on methamphetamine and 3,4-methylened... J Neurochem 1996
Chu T, Kumagai Y, DiStefa... Disposition of methylenedioxymethamphetamine and three metabolites in ... Biochem Pharmacol 1996
Miller DB, O'Callaghan JP Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interac... Ann N Y Acad Sci 1996
Miller RT, Lau SS, Monks ... 2,5-bis-(Glutathion-S-yl)-alpha-methyldopamine, a putative metabolite ... Eur J Pharmacol 1997
Kombian SB, Saleh TM, Fia... Ibogaine and a total alkaloidal extract of Voacanga africana modulate ... Brain Res Bull 1997
Lindefors N, Barati S, O'... Differential effects of single and repeated ketamine administration on... Brain Res 1997
Kankaanpaa A, Meririnne E... The acute effects of amphetamine derivatives on extracellular serotoni... Pharmacol Biochem Be... 1998
Bai F, Lau SS, Monks TJ Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine pr... Chem Res Toxicol 1999
Arvanov VL, Liang X, Russ... LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA recepto... Eur J Neurosci 1999
Schatz DS, Kaufmann WA, S... 3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein ... Synapse 2000
Shirayama Y, Hashimoto K,... 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA i... Eur J Pharmacol 2000
Mansvelder HD, McGehee DS Long-term potentiation of excitatory inputs to brain reward areas by n... Neuron 2000
Bai F, Jones DC, Lau SS, ... Serotonergic Neurotoxicity of 3,4-(+/-)-Methylenedioxyamphetamine and ... Chem Res Toxicol 2001
Russell BR, Laverty R The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-in... Pharmacology, Bioche... 2001
O'Loinsigh ED, Boland G, ... Behavioural, hyperthermic and neurotoxic effects of 3,4- methylenediox... Prog Neuropsychophar... 2001
Baumann MH, Pablo J, Ali ... Comparative neuropharmacology of ibogaine and its O-desmethyl metaboli... Alkaloids Chem Biol 2001
Carvalho M, Hawksworth G,... Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vi... Arch Toxicol 2002
Lebsanft HB, Mayerhofer A... Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unila... J Neural Transm 2003
Easton N, Fry J, O'Shea E... Synthesis, in vitro formation, and behavioural effects of glutathione ... Brain Res 2003
Carvalho M, Milhazes N, R... Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopami... Arch Toxicol 2003
Narendran R, Frankle WG, ... Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketam... Am J Psychiatry 2005
Capela JP, Macedo C, Bran... Neurotoxicity mechanisms of thioether ecstasy metabolites Neuroscience 2007
Litjens RP, Brunt TM How toxic is ibogaine? Clin Toxicol (Phila) 2016
Wallach J, Kang H, Colest... Pharmacological Investigations of the Dissociative 'Legal Highs' Diphe... PLoS One 2016
Kang H, Park P, Bortolott... Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor ... Neuropharmacology 2017
Ingram R, Kang H, Lightma... Some distorted thoughts about ketamine as a psychedelic and a novel hy... Neuropharmacology 2018
Botanas CJ, de la Peņa JB... Methoxetamine: A foe or friend? Neurochem Int 2019